We selected SARS‐CoV‐2 as a model to represent emerging viruses; however, the impact of this work will be far‐reaching because IFN‐β also has therapeutic applications in other diseases including bacterial infections, autoimmune disorders, and solid tumors.69, 70. Here, IFNB1 is linked to bacterial infectious disease.